BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 40.92
+0.65 (1.61%)
At close: Mar 6, 2026
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 17.3 billion as of March 6, 2026. Its market cap has increased by 36.61% in one year.
Market Cap
17.30B
Enterprise Value
19.12B
Revenue
1.22B
Ranking
n/a
PE Ratio
308.59
Stock Price
40.92
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 17.30B, an increase of 37.84%. That is a compound annual growth rate of 5.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 17.02B | -17.92% |
| Dec 31, 2025 | 20.74B | 62.70% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yili Chuanning Biotechnology | 23.57B |
| Suzhou Zelgen Biopharmaceuticals | 20.57B |
| Sinocelltech Group | 16.52B |
| Jinyu Bio-technology | 16.25B |
| Anhui Anke Biotechnology (Group) | 15.70B |
| Inner Mongolia Furui Medical Science | 14.76B |
| Tibet Cheezheng Tibetan Medicine | 14.21B |
| Pacific Shuanglin Bio-pharmacy | 13.20B |